367 related articles for article (PubMed ID: 22822074)
1. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
2. Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.
Feng Y; Chelico L
J Biol Chem; 2011 Apr; 286(13):11415-26. PubMed ID: 21300806
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3G.
Feng Y; Love RP; Chelico L
J Biol Chem; 2013 Mar; 288(9):6083-94. PubMed ID: 23316055
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
5. Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.
Ara A; Love RP; Chelico L
PLoS Pathog; 2014 Mar; 10(3):e1004024. PubMed ID: 24651717
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
7. AID and Apobec3G haphazard deamination and mutational diversity.
Jaszczur M; Bertram JG; Pham P; Scharff MD; Goodman MF
Cell Mol Life Sci; 2013 Sep; 70(17):3089-108. PubMed ID: 23178850
[TBL] [Abstract][Full Text] [Related]
8. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.
Rathore A; Carpenter MA; Demir Ö; Ikeda T; Li M; Shaban NM; Law EK; Anokhin D; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2013 Nov; 425(22):4442-54. PubMed ID: 23938202
[TBL] [Abstract][Full Text] [Related]
9. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
[TBL] [Abstract][Full Text] [Related]
10. Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution.
Senavirathne G; Jaszczur M; Auerbach PA; Upton TG; Chelico L; Goodman MF; Rueda D
J Biol Chem; 2012 May; 287(19):15826-35. PubMed ID: 22362763
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
Bélanger K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
12. Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G.
Wijesinghe P; Bhagwat AS
Nucleic Acids Res; 2012 Oct; 40(18):9206-17. PubMed ID: 22798497
[TBL] [Abstract][Full Text] [Related]
13. The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action.
Coker HA; Petersen-Mahrt SK
DNA Repair (Amst); 2007 Feb; 6(2):235-43. PubMed ID: 17161027
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances in the study of mechanism of APOBEC3G against virus].
Zhu YP; Jiang JD; Peng ZG
Yao Xue Xue Bao; 2014 Jan; 49(1):30-6. PubMed ID: 24783502
[TBL] [Abstract][Full Text] [Related]
15. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
16. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
[TBL] [Abstract][Full Text] [Related]
17. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
18. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
20. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Browne EP; Allers C; Landau NR
Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
